Omnicell Inc - Asset Resilience Ratio
Omnicell Inc (OMCL) has an Asset Resilience Ratio of 0.74% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Omnicell Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Omnicell Inc's Asset Resilience Ratio has changed over time. See Omnicell Inc (OMCL) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Omnicell Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Omnicell Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $14.65 Million | 0.74% |
| Total Liquid Assets | $14.65 Million | 0.74% |
Asset Resilience Insights
- Limited Liquidity: Omnicell Inc maintains only 0.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Omnicell Inc Industry Peers by Asset Resilience Ratio
Compare Omnicell Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS |
Health Information Services | 0.39% |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY |
Health Information Services | 2.13% |
|
DocCheck AG
XETRA:AJ91 |
Health Information Services | 7.30% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
Annual Asset Resilience Ratio for Omnicell Inc (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Omnicell Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.74% | $14.65 Million | $1.97 Billion | +0.15pp |
| 2024-12-31 | 0.59% | $12.47 Million | $2.12 Billion | -0.89pp |
| 2023-12-31 | 1.48% | $33.01 Million | $2.23 Billion | +0.96pp |
| 2022-12-31 | 0.52% | $11.49 Million | $2.21 Billion | +0.02pp |
| 2021-12-31 | 0.50% | $10.66 Million | $2.14 Billion | -0.06pp |
| 2020-12-31 | 0.56% | $10.25 Million | $1.82 Billion | -0.23pp |
| 2019-12-31 | 0.79% | $9.77 Million | $1.24 Billion | -- |
| 2017-12-31 | 0.00% | $0.00 | $980.30 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $935.10 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $578.75 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $560.21 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $492.50 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $443.73 Million | -- |
| 2011-12-31 | 2.24% | $8.11 Million | $361.97 Million | -0.11pp |
| 2010-12-31 | 2.35% | $8.07 Million | $343.30 Million | -8.82pp |
| 2004-12-31 | 11.17% | $11.12 Million | $99.49 Million | +0.49pp |
| 2003-12-31 | 10.68% | $9.03 Million | $84.47 Million | +10.55pp |
| 2002-12-31 | 0.13% | $85.00K | $65.54 Million | -9.48pp |
| 2001-12-31 | 9.61% | $6.93 Million | $72.11 Million | +4.40pp |
| 2000-12-31 | 5.21% | $2.29 Million | $43.91 Million | -- |
About Omnicell Inc
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for th… Read more